August 8, 2011 — Controller medications and follow-up are underused in young patients hospitalized for asthma, according to the results of a retrospective analysis of South Carolina Medicaid data from ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up Nearly half of children and adults with persistent asthma – 49 ...

Reduced cost-sharing for asthma medications improved adherence to controller medications among patients with severe asthma. Preventative drug lists (PDLs) for asthma medications, such as combination ...

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications. Tezepelumab reduced annual ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

NEW YORK (Reuters Health) - New research suggests that adherence with daily asthma "controller" medications among children with asthma can be enhanced with school-based supervised asthma therapy. As ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

Are you one of those families racing to find new asthma medications as respiratory virus season approaches? The Massachusetts Department of Public Health is trying to help patients and families access ...

Please provide your email address to receive an email when new articles are posted on . Mean annual total expenditures on asthma-related medications was $322. The 2% deductible for patients increased ...